Bioduro

San Diego, United States Founded: 2005 • Age: 21 yrs Acquired By Advent International
Integrated drug discovery and development services

About Bioduro

Bioduro is a Healthcare company based in San Diego (United States) founded in 2005, and was acquired by Advent International in January 2019. Integrated drug discovery and development services. Bioduro has completed 1 acquisition, including Molecular Response. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Medicinal Chemistry.

Company details

BioDuro was founded in 2005 in San Diego, United States, as a contract research, development, and manufacturing entity within the biopharmaceutical sector. Integrated services are delivered for drug discovery, encompassing compound synthesis and optimization across medicinal chemistry, biology, pharmacology, drug metabolism, pharmacokinetics, and safety evaluations. Operations extend to phase II-IV clinical management, data handling, biostatistics, cGMP production of drug products up to phase II, and clinical storage support.

  • Headquarters San Diego, United States
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Website bioduro.com
  • Social LinkedIn
  • Acquired by Advent International (Jan 2019)
Key Metrics

Investors in Bioduro

Bioduro has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include PPD and Advent International.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Private equity firm focused on multiple sectors
adventinternational.comSao Paulo, Brazil
CRO providing diversified clinical development services
1985ppd.comWilmington, United States
Premium access

Investor details for Bioduro

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Bioduro

15 people are tracked at Bioduro (6 in leadership, 7 in board & advisors, 2 in team).

NameRoleGroup
Jim Li
President, Global CMC Solutions - ChinaLeadership
Roy Xu
Chief Strategy OfficerLeadership
Wynn Thai
Sr. Director, Business DevelopmentLeadership
Ping Zhang
Director, Integrated Service And Alliance, Project ManagementLeadership
Ricardo Inacio
Executive DirectorLeadership
Ajiroghene Thomas
Director Of Business DevelopmentLeadership
Andrew Li
DirectorBoard & advisors
Cathy Yen
DirectorBoard & advisors
Kewen Jin
DirectorBoard & advisors
Amit Patel
DirectorBoard & advisors
Masood Tayebi
DirectorBoard & advisors
David Preston
ChairmanBoard & advisors
Michael Miltenberger
DirectorBoard & advisors
Alice Lv
SVP, OperationsTeam
Tyler Christian Chiuppi
Quality Assurance Raw MaterialsTeam
Premium access

Complete people profiles for Bioduro

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Bioduro

Bioduro has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Molecular Response.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Specializes in biospecimen storage and tumor biobanking services.
molecularresponse.comSan Diego, United States2010Mar 2018β€’β€’β€’β€’
Premium access

Complete acquisition details for Bioduro

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Bioduro

4 dated milestones of Bioduro across 14 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bioduro is founded.
  2. Exit Acquired by PPD.
  3. Acquisition Acquires Molecular Response.
  4. Exit Acquired by Advent International.

Web traffic of Bioduro

The website of Bioduro (bioduro.com) receives about 6.9K visits a month and ranks #3,126,038 among all websites worldwide, #4,117 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    6.9K

    ▲ 33% vs previous month

  • Unique visitors
    2.4K

    per month

  • Global rank
    #3,126,038

    among all websites

  • Category rank
    #4,117

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Bioduro. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cmocro.com
100%
21.8K#1,242,657View details
sdbn.org
sdbn.org
92%
#2,959,554–
yangzijiang.com
89%
#559,311View details
wuxiapptec.com
89%
107.6K#296,852View details
syngeneintl.com
86%
94K#525,515View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for Bioduro

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Bioduro (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Suite solutions are provided for payers and healthcare providers.
1998Princeton, New Jersey, United StatesUSD 220 MUSD 374.1 M5,666
Wearable insulin infusion systems are developed for diabetes patients.
2000Boston, Massachusetts, United StatesUSD 120.4 MUSD 2.71 B3,900
Developer of small-molecule drugs
1991Los Angeles, California, United StatesUSD 50 MUSD 348.97 M407
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bioduro

Premium access

Complete news archive for Bioduro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bioduro

Bioduro was founded in 2005.

Bioduro is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

BioDuro was founded in 2005 in San Diego, United States, as a contract research, development, and manufacturing entity within the biopharmaceutical sector. Integrated services are delivered for drug discovery, encompassing compound synthesis and optimization across medicinal chemistry, biology, pharmacology, drug metabolism, pharmacokinetics, and safety evaluations. Operations extend to phase II-IV clinical management, data handling, biostatistics, cGMP production of drug products up to phase II, and clinical storage support.

Bioduro has made 1 acquisition, including Molecular Response.

Bioduro has 2 investors. Key investors include PPD, and Advent International.

Yes. Bioduro was acquired by Advent International in January 2019.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available